Skip to main content

William W. O'Neill, MD

06/19/2008
When did you first start using the Cribier-Edwards percutaneous aortic heart valve? We received FDA approval in August 2003 for a one-time compassionate use. Dr. Alain Cribier, who did the first human clinical implants with the valve, had...
When did you first start using the Cribier-Edwards percutaneous aortic heart valve? We received FDA approval in August 2003 for a one-time compassionate use. Dr. Alain Cribier, who did the first human clinical implants with the valve, had...
When did you first start using...
06/19/2008
Cath Lab Digest
Original Contribution
08/01/2022
In STEMI, infarct size (IS) directly correlates with major cardiovascular outcomes. Preclinical models demonstrate mechanical LV unloading before reperfusion reduces IS. The door-to-unload (DTU)-STEMI pilot trial evaluated the safety and...
In STEMI, infarct size (IS) directly correlates with major cardiovascular outcomes. Preclinical models demonstrate mechanical LV unloading before reperfusion reduces IS. The door-to-unload (DTU)-STEMI pilot trial evaluated the safety and...
In STEMI, infarct size (IS)...
08/01/2022
Journal of Invasive Cardiology
Commentary
09/29/2011
You can liken performance of high-risk percutaneous coronary intervention (PCI) to attempting to repair a damaged car engine while it is turned on. Moreover, that car is trying to slowly drive away from a steep cliff with the ocean crashing...
You can liken performance of high-risk percutaneous coronary intervention (PCI) to attempting to repair a damaged car engine while it is turned on. Moreover, that car is trying to slowly drive away from a steep cliff with the ocean crashing...
You can liken performance of...
09/29/2011
Journal of Invasive Cardiology
04/29/2015
Patients with atrial fibrillation and contraindications to anticoagulation have limited options for left atrial appendage (LAA) closure until approval of dedicated closure devices; off-label use of available cardiac devices represents one...
Patients with atrial fibrillation and contraindications to anticoagulation have limited options for left atrial appendage (LAA) closure until approval of dedicated closure devices; off-label use of available cardiac devices represents one...
Patients with atrial...
04/29/2015
Journal of Invasive Cardiology
Clinical Images
07/30/2021
The LAmbre device offers an alternative for patients who may not qualify for conventional LAA occlusion devices. We describe its use in a 79-year-old male patient with non-valvular atrial fibrillation and multiple falls who was considered...
The LAmbre device offers an alternative for patients who may not qualify for conventional LAA occlusion devices. We describe its use in a 79-year-old male patient with non-valvular atrial fibrillation and multiple falls who was considered...
The LAmbre device offers an...
07/30/2021
Journal of Invasive Cardiology
Feature
06/19/2008
Greg Braden: Let’s discuss the issue of MI patients who live in communities where there is quick access to catheterization laboratories, versus those in remote communities who don’t have easy access to cath labs. We live in a modestly rural...
Greg Braden: Let’s discuss the issue of MI patients who live in communities where there is quick access to catheterization laboratories, versus those in remote communities who don’t have easy access to cath labs. We live in a modestly rural...
Greg Braden: Let’s discuss the...
06/19/2008
Cath Lab Digest
New Devices
07/08/2014
Transcatheter aortic valve replacement (TAVR) can be complicated by significant paravalvular leak (PVL). The aim of this study was to assess the utility of a proprietary software package, HeartNavigator (Philips), in selecting TAVR prosthesis...
Transcatheter aortic valve replacement (TAVR) can be complicated by significant paravalvular leak (PVL). The aim of this study was to assess the utility of a proprietary software package, HeartNavigator (Philips), in selecting TAVR prosthesis...
Transcatheter aortic valve...
07/08/2014
Journal of Invasive Cardiology
Clinical Images
09/01/2021
A 55-year-old woman with no medical history presented with left cerebellar stroke after presenting 2 weeks prior for recurrent acute left upper-arm limb ischemia requiring thrombectomy.
A 55-year-old woman with no medical history presented with left cerebellar stroke after presenting 2 weeks prior for recurrent acute left upper-arm limb ischemia requiring thrombectomy.
A 55-year-old woman with no...
09/01/2021
Journal of Invasive Cardiology